Ausgabe Sonderheft 2/2008
Proceedings of the Experts Meeting on Lung Cancer and the Use of Erlotinib
Inhalt (4 Artikel)
Open Access
Proceedings
Overview of advanced non-small-cell lung cancer treatment in Mexico
Víctor Lira Puerto
Open Access
Proceedings
First- and second-line treatment of advanced metastatic non-small-cell lung cancer: a global view
Nicholas Thatcher
Open Access
Proceedings
Conclusions of the expert panel: importance of erlotinib as a second-line therapeutic option
Aldo Castagnari